CEO Michael Farrell was paid $16,201,649 in fiscal year 2026, ↑ up 10.4% from fiscal year 2025, the 73rd percentile of its disclosed peer group (SEC filing 0000943819-26-000080 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$16,201,649 ↑ Michael Farrell total, FY2026 | 73rd CEO pay percentile vs peers | 199:1 CEO-to-median pay ratio | 89.94% Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
Ask our research desk — $99, 24h, every figure cited to its filing.
RMD's next annual pay disclosure, estimated September 30, 2027.est. Filing ↗
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Michael Farrell | $1,272,895 | $0 | $9,749,468 | $3,249,907 | $1,738,857 | $0 | $190,522 | $16,201,649 |
| Chief executive officer | ||||||||
| Justin Leong | 752,928 | 0 | 3,099,837 | 0 | 609,510 | 0 | 94,846 | 4,557,121 |
| Chief product officer | ||||||||
| Brett Sandercock | 600,164 | 0 | 2,599,517 | 0 | 485,845 | 0 | 82,477 | 3,768,003 |
| Former chief financial officer and special advisor to CEO | ||||||||
| Aaron Bloomer | 114,550 | 0 | 3,300,066 | 0 | 92,731 | 0 | 8,960 | 3,516,307 |
| Chief financial officer | ||||||||
| Michael Rider | 535,405 | 0 | 1,549,527 | 0 | 325,066 | 0 | 55,015 | 2,465,013 |
| Global general counsel and secretary | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2026 total | FY2025 total | FY2024 total | Δ FY2025→2026 |
|---|---|---|---|---|
| Michael Farrell | $16,201,649 | $14,674,543 | $14,120,829 | ↑ +1,527,106 |
| Justin Leong | 4,557,121 | 3,911,441 | 3,597,240 | ↑ +645,680 |
| Brett Sandercock | 3,768,003 | 3,572,010 | 3,233,565 | ↑ +195,993 |
| Aaron Bloomer | 3,516,307 | — | — | — |
| Michael Rider | 2,465,013 | 2,289,122 | 2,154,393 | ↑ +175,891 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read RESMED INC's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper RMD reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
Get the RESMED INC Peer Teardown Report
$16,201,649 Michael Farrell total, FY2026
$199
The free page is the headline. The teardown reads every company in the disclosed peer group on its own numbers.
Data as of October 8, 2026 · Source: 0000943819-26-000080 · Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
Reports for RMD
Every report below is generated from the same filings as the free brief above, at the moment of purchase. What each one adds:
Order RMD
Pick the report, add the email the receipt and the PDF go to, and pay by card on Stripe.
How we handle your data → Privacy
The list of companies that name RMD as a peer is temporarily unavailable — recheck shortly.
Get the RESMED INC Executive Compensation Report
$1,500
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2026 total |
|---|---|---|
| Carol Burt | Independent Director | $351,910 |
| Christopher DelOrefice | Independent Director | $359,827 |
| Desney Tan | Independent Director | $334,827 |
| Harjit Gill | Independent Director | $349,827 |
| Jan De Witte | Independent Director | $334,827 |
| John Hernandez | Independent Director | $334,827 |
| Karen Drexler | Independent Director | $354,827 |
| Nicole Mowad-Nassar | Independent Director | $374,347 |
| Peter Farrell | Director | $680,601 |
| Richard Sulpizio | Independent Director | $37,500 |
| Ronald Taylor | Lead Independent Director | $374,827 |
Every insider equity transaction reported on Form 4 after the 2026 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Michael J. Farrell | Director | 2026-10-07 | D | 4,991 | $0 | $0 | Derivative, Class A Common | Form 4 ↗ |
| Michael J. Farrell | Director | 2026-10-07 | D | 4,991 | 226 | 1,129,637 | Common, open-market sale | Form 4 ↗ |
| Michael J. Farrell | Director | 2026-10-07 | A | 4,991 | 146 | 730,383 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Michael Farrell | OPTION | 2025-11-24 | — | — | 33,288 | — | $3,249,907 |
| Michael Rider | PSU | 2025-11-20 | 622 | 1,383 | — | 2,766 | 387,337 |
| Brett Sandercock | PSU | 2025-11-20 | 2,710 | 5,419 | — | 5,419 | 1,299,964 |
| Brett Sandercock | PSU | 2025-11-20 | 1,044 | 2,320 | — | 4,640 | 649,762 |
| Aaron Bloomer | PSU | 2026-06-01 | 4,536 | 9,072 | — | 9,072 | 1,649,925 |
| Michael Farrell | PSU | 2025-11-20 | 6,774 | 13,547 | — | 13,547 | 3,249,790 |
| Michael Farrell | PSU | 2025-11-20 | 6,167 | 12,333 | — | 24,666 | 3,249,746 |
| Michael Farrell | PSU | 2025-11-20 | 5,222 | 11,604 | — | 23,208 | 3,249,932 |
| Justin Leong | PSU | 2025-11-20 | 1,245 | 2,767 | — | 5,534 | 774,954 |
| Justin Leong | PSU | 2025-11-20 | 3,231 | 6,461 | — | 6,461 | 1,549,929 |
| Michael Rider | PSU | 2025-11-20 | 1,615 | 3,230 | — | 3,230 | 774,845 |
| Michael Rider | PSU | 2025-11-20 | 735 | 1,470 | — | 2,940 | 387,345 |
| Brett Sandercock | PSU | 2025-11-20 | 1,233 | 2,466 | — | 4,932 | 649,791 |
| Aaron Bloomer | PSU | 2026-06-01 | 2,059 | 4,118 | — | 8,236 | 825,041 |
| Aaron Bloomer | PSU | 2026-06-01 | 1,726 | 3,835 | — | 7,670 | 825,100 |
| Justin Leong | PSU | 2025-11-20 | 1,471 | 2,941 | — | 5,882 | 774,954 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Michael Farrell | $0 | $9,749,468 | $3,249,907 | 75.0% |
| Michael Rider | 0 | 1,549,527 | 0 | 100.0% |
| Brett Sandercock | 0 | 2,599,517 | 0 | 100.0% |
| Aaron Bloomer | 0 | 3,300,066 | 0 | 100.0% |
| Justin Leong | 0 | 3,099,837 | 0 | 100.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Farrell | PSU | 24,588 | — | $4,791,709 |
| Brett Sandercock | RSU | 1,219 | — | 237,559 |
| Farrell | RSU | 16,913 | — | 3,296,005 |
| Farrell | RSU | 14,617 | — | 2,848,561 |
| Justin Leong | RSU | 1,471 | — | 286,668 |
| Farrell | PSU | 13,547 | — | 2,640,039 |
| Aaron Bloomer | RSU | 9,072 | — | 1,767,951 |
| Aaron Bloomer | RSU | 7,670 | — | 1,494,730 |
| Brett Sandercock | RSU | 6,281 | — | 1,224,041 |
| Justin Leong | PSU | 6,461 | — | 1,259,120 |
| Justin Leong | RSU | 6,395 | — | 1,246,258 |
| Farrell | RSU | 6,167 | — | 1,201,825 |
| Justin Leong | PSU | 6,146 | — | 1,197,732 |
| Brett Sandercock | PSU | 5,891 | — | 1,148,038 |
| Farrell | RSU | 5,483 | — | 1,068,527 |
| Michael Rider | PSU | 3,330 | — | 648,950 |
| Brett Sandercock | PSU | 5,419 | — | 1,056,055 |
| Farrell | RSU | 5,222 | — | 1,017,663 |
| Farrell | RSU | 4,727 | — | 921,198 |
| Farrell | RSU | 4,098 | — | 798,618 |
| Michael Rider | RSU | 3,793 | — | 739,180 |
| Justin Leong | RSU | 3,624 | — | 706,245 |
| Michael Rider | PSU | 3,230 | — | 629,462 |
| Brett Sandercock | RSU | 3,473 | — | 676,818 |
| Aaron Bloomer | RSU | 2,059 | — | 401,258 |
| Michael Rider | RSU | 1,963 | — | 382,549 |
| Justin Leong | RSU | 1,050 | — | 204,624 |
| Justin Leong | RSU | 1,245 | — | 242,626 |
| Justin Leong | Option | 8,134 | 263.16 | — |
| Brett Sandercock | RSU | 1,233 | — | 240,287 |
| Justin Leong | RSU | 1,219 | — | 237,559 |
| Brett Sandercock | RSU | 1,050 | — | 204,624 |
| Brett Sandercock | RSU | 1,044 | — | 203,455 |
| Justin Leong | RSU | 878 | — | 171,105 |
| Brett Sandercock | RSU | 841 | — | 163,894 |
| Michael Rider | RSU | 735 | — | 143,237 |
| Michael Rider | RSU | 656 | — | 127,841 |
| Michael Rider | RSU | 622 | — | 121,215 |
| Michael Rider | RSU | 566 | — | 110,302 |
| Michael Rider | RSU | 476 | — | 92,763 |
| Farrell | Option | 33,288 | 250.52 | — |
| Farrell | Option | 22,024 | 249.56 | — |
| Farrell | Option | 18,490 | 148.9 | — |
| Farrell | Option | 36,569 | 224.58 | — |
| Farrell | Option | 24,957 | 146.34 | — |
| Justin Leong | Option | 9,973 | 224.58 | — |
| Justin Leong | Option | 4,187 | 190.86 | — |
Our executive compensation philosophy is to be guided by salaries for high performing and experienced officers among our US peer group.
| CEO STI target (% of salary) | 135% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | FW Cook |
| Clawback policy | True |
| Anti-hedging | True |
| Anti-pledging | True |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2025 | 2025-11-19 | 98,435,762 | 11,004,916 | 236,395 | 89.94% | Passed |
| 2024 | 2024-11-20 | 92,885,004 | 17,284,647 | 87,620 | 84.31% | Passed |
| 2023 | 2023-11-16 | 84,318,661 | 19,649,791 | 77,972 | 81.1% | Passed |
| 2022 | 2022-11-16 | 103,364,254 | 11,566,190 | 254,814 | 89.94% | Passed |
| 2021 | 2021-11-18 | 99,221,728 | 12,231,321 | 220,184 | 89.03% | Passed |
| 2020 | 2020-11-19 | 101,981,838 | 9,669,839 | 137,628 | 91.34% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2025 | 2025-11-19 | 89.94%a |
| 2024 | 2024-11-20 | 84.31%b |
| 2023 | 2023-11-16 | 81.1%c |
a. Approved under the standard stated in the filing — “Abstentions and broker non-votes do not count as votes cast and thus will not affect the outcome of this proposal.”.
b. Approved under the standard stated in the filing — “Abstentions and broker non-votes do not count as votes cast and thus will not affect the outcome of this proposal.”.
c. Approved under the standard stated in the filing — “Abstentions and broker non-votes do not count as votes cast and 5 Table of Contents thus will not affect the outcome of this proposal.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 199 : 1 |
|---|---|
| CEO total compensation | — |
| Median employee compensation | $81,585 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Peter FarrellEmployee director | $75,000 | $129,792 | $129,946 | — | $345,863 | $680,601 |
| Ronald TaylorIndependent · Lead Independent Director · Audit · Compliance, Privacy and Quality · Nominating and Governance | 115,000 | 259,827 | — | — | 0 | 374,827 |
| Nicole Mowad-NassarIndependent · Compliance, Privacy and Quality | 56,250 | 188,151 | 129,946 | — | 0 | 374,347 |
| Christopher DelOreficeIndependent · Audit (Chair) | 100,000 | 259,827 | — | — | 0 | 359,827 |
| Karen DrexlerIndependent · Compensation and Leadership Development (Chair) · Compliance, Privacy and Quality · Nominating and Governance | 95,000 | 259,827 | — | — | 0 | 354,827 |
| Carol BurtIndependent · Audit · Compliance, Privacy and Quality · Nominating and Governance (Chair) | 92,083 | 259,827 | — | — | 0 | 351,910 |
| Harjit GillIndependent · Audit · Compensation and Leadership Development · Compliance, Privacy and Quality (Chair) | 90,000 | 259,827 | — | — | 0 | 349,827 |
| John HernandezIndependent · Audit · Compliance, Privacy and Quality | 75,000 | 259,827 | — | — | 0 | 334,827 |
| Desney TanIndependent · Compensation and Leadership Development · Nominating and Governance | 75,000 | 259,827 | — | — | 0 | 334,827 |
| Jan De WitteIndependent · Audit · Compensation and Leadership Development · Nominating and Governance | 75,000 | 259,827 | — | — | 0 | 334,827 |
| Richard SulpizioIndependent · Not standing for re-election · Departed during FY | 37,500 | 0 | 0 | — | 0 | 37,500 |
| Michael FarrellEmployee director · Board Chair | — | — | — | — | — | 0 |
| Annual cash retainer | $75,000 |
|---|---|
| Annual equity retainer | $260,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 20,000 / 15,000 |
| Stock ownership guideline | $5 |
| Component | FY2026 |
|---|---|
| Cash retainers and fees | $885,833 |
| Equity awards (grant-date value) | $2,396,559 |
| All other compensation | $345,863 |
| Total cost of the board | $3,628,255 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies RESMED INC names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including RESMED INC.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Baxter International, Inc. | 2025 | Andrew Hider | $499,315 | $23,133,518 | $3,185,053 | $820,125 | $29,805,182 |
| 2 | Intuitive Surgical, Inc. | 2025 | David Rosa | 858,750 | 18,674,872 | 0 | 1,373,859 | 20,997,480 |
| 3 | Align Technology, Inc. | 2025 | Joseph Hogan | 1,400,000 | 16,556,872 | 0 | 1,220,100 | 19,193,988 |
| 4 | Edwards Lifesciences Corp. | 2025 | Bernard Zovighian | 1,192,500 | 7,167,024 | 6,499,109 | 2,406,537 | 17,454,255 |
| 5 | RESMED INC | 2026 | Michael Farrell | 1,272,895 | 9,749,468 | 3,249,907 | 1,738,857 | 16,201,649 |
| 6 | The Cooper Companies Inc. | 2025 | Albert White III | 1,170,769 | 6,642,918 | 6,643,050 | 1,525,951 | 16,051,141 |
| 7 | Hologic Inc. | 2024 | Stephen MacMillan | 1,212,628 | 9,141,468 | 2,937,477 | 1,990,413 | 15,819,261 |
| 8 | Charles River Laboratories International, Inc. | 2025 | James Foster | 1,545,636 | 11,601,089 | 0 | 2,182,666 | 15,435,220 |
| 9 | IDEXX Laboratories, Inc. | 2025 | Jonathan Mazelsky | 1,150,000 | 5,399,881 | 5,400,001 | 2,593,000 | 14,580,122 |
| 10 | Waters Corporation | 2025 | Udit Batra | 1,150,000 | 7,430,247 | 2,999,922 | 2,371,875 | 13,973,044 |
| 11 | Agilent Technologies, Inc. | 2025 | Padraig McDonnell | 1,141,345 | 8,169,850 | 2,017,759 | 1,436,809 | 12,827,236 |
| 12 | Xero | 2025 | Steven Bandrowczak | 1,100,000 | 11,466,184 | 0 | 0 | 12,581,826 |
| 13 | Illumina, Inc. | 2025 | Jacob Thaysen | 1,000,000 | 8,763,122 | 0 | 1,155,000 | 11,018,895 |
| 14 | Bio-Rad Laboratories, Inc. | 2025 | Norman Schwartz | 1,089,877 | 4,856,574 | 1,458,975 | 562,088 | 7,995,841 |
| 15 | Dexcom, Inc. | 2025 | Jacob Leach | 768,962 | 5,936,062 | 0 | 1,164,780 | 7,985,960 |
| 16 | Mettler-Toledo International Inc. | 2025 | Patrick Kaltenbach | 1,145,999 | 3,267,808 | 1,635,033 | 462,984 | 6,741,212 |
| 17 | Teleflex Incorporated | 2025 | Liam Kelly | 1,144,400 | 2,005,604 | 2,886,518 | 227,280 | 6,732,419 |
| 18 | James Hardie Industries PLC | 2026 | Aaron Erter | 1,120,335 | 4,658,716 | 0 | 703,872 | 6,545,953 |
| — | Amcor | — | — | — | — | — | — | not in coverage universe |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| RESMED INC | not disclosed | PSU 50 · RSU 25 · Options 25 | Yes — Relative TSR | FW Cook |
| Agilent Technologies, Inc. | not disclosed | PSU 60 · Options 20 · RSU 20 | No | Semler Brossy |
| Align Technology, Inc. | 58.1% | MSU 70 · RSU 30 | Yes — Relative Total Stockholder Return (TSR) vs. Nasdaq Composite Index | Compensia, Inc. |
| Amcor | 71% | PSU 60 · Option 20 · RSU 20 | Yes — Relative TSR | FW Cook |
| Baxter International, Inc. | not disclosed | not disclosed | No | Aon Consulting, Inc. (Aon) |
| Bio-Rad Laboratories, Inc. | not disclosed | not disclosed | not disclosed | Compensia, Inc. |
| Charles River Laboratories International, Inc. | 139% | PSU 60 · RSU 40 | Yes — Three-year rTSR | Pay Governance |
| Dexcom, Inc. | not disclosed | not disclosed | Yes — Relative TSR Performance Metric | Aon Hewitt Consulting Company |
| Edwards Lifesciences Corp. | 127% | Options 50 · PSU 25 · RSU 25 | No | Semler Brossy Consulting Group |
| Hologic Inc. | 109% | PSU 50 · RSU 25 · Option 25 | No | Pearl Meyer & Partners, LLC |
| IDEXX Laboratories, Inc. | 140% | Options 50 · PSU 50 | No | Farient |
| Illumina, Inc. | 1155% | not disclosed | Yes — 3-year rTSR performance against select companies in the Nasdaq Biotechnology Index | Aon (Aon's Human Capital Practice, a division of Aon, plc) |
| Intuitive Surgical, Inc. | 115.2% | RSU 50 · PSU 50 | No | Aon |
| James Hardie Industries PLC | not disclosed | ROCE PRSU 33 · TSR PRSU 33 · Scorecard LTI 33 | Yes — TSR PRSU | not disclosed |
| Mettler-Toledo International Inc. | not disclosed | not disclosed | Yes — Relative Total Shareholder Return (rTSR) | Pearl Meyer & Partners |
| Teleflex Incorporated | 25.9% | Options 55 · RSU 25 · PSU 20 | Yes — Absolute TSR | FW Cook |
| The Cooper Companies Inc. | 100.9% | Options 50 · PSU 50 | No | Compensia |
| Waters Corporation | 110% | PSU 50 · Options 35 · RSU 15 | Yes — Relative Total Shareholder Return (rTSR) | Pearl Meyer |
| Xero | not disclosed | PSU 50 · RSU 50 | No | Pay Governance LLC |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Michael Farrell | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Executive Compensation Tables” · page 70. As printed: 16,201,649. Filing ↗machine: span 1267106–1267116 |
| 2 | Section 01, Justin Leong | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Executive Compensation Tables” · page 70. As printed: 4,557,121. Filing ↗machine: span 1285959–1285968 |
| 3 | Section 01, Brett Sandercock | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Executive Compensation Tables” · page 70. As printed: 3,768,003. Filing ↗machine: span 1312771–1312780 |
| 4 | Section 01, Aaron Bloomer | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Executive Compensation Tables” · page 70. As printed: 3,516,307. Filing ↗machine: span 1280590–1280599 |
| 5 | Section 01, Michael Rider | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Executive Compensation Tables” · page 70. As printed: 2,465,013. Filing ↗machine: span 1299361–1299370 |
| 6 | Section 03, Michael Farrell OPTION | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1386091–1386100 |
| 7 | Section 03, Michael Rider PSU | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1416733–1416740 |
| 8 | Section 03, Brett Sandercock PSU | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1434961–1434970 |
| 9 | Section 03, Brett Sandercock PSU | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1428975–1428982 |
| 10 | Section 03, Aaron Bloomer PSU | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1398300–1398309 |
| 11 | Section 03, Michael Farrell PSU | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1383398–1383407 |
| 12 | Section 03, Michael Farrell PSU | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1380403–1380412 |
| 13 | Section 03, Michael Farrell PSU | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1377406–1377415 |
| 14 | Section 03, Justin Leong PSU | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1404522–1404529 |
| 15 | Section 03, Justin Leong PSU | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1410508–1410517 |
| 16 | Section 03, Michael Rider PSU | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1422717–1422724 |
| 17 | Section 03, Michael Rider PSU | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1419726–1419733 |
| 18 | Section 03, Brett Sandercock PSU | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1431970–1431977 |
| 19 | Section 03, Aaron Bloomer PSU | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1395311–1395318 |
| 20 | Section 03, Aaron Bloomer PSU | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1392318–1392325 |
| 21 | Section 03, Justin Leong PSU | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1407517–1407524 |
| 22 | Section 07, pay ratio | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “CEO Pay Ratio”. As printed: 199 : 1. Filing ↗machine: span 1812927–1812930 |
| 23 | Section 08, Peter Farrell | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Director Compensation”. As printed: 680,601. Filing ↗machine: span 731659–731799 |
| 24 | Section 08, Ronald Taylor | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Director Compensation”. As printed: 374,827. Filing ↗machine: span 750762–750902 |
| 25 | Section 08, Nicole Mowad-Nassar | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Director Compensation”. As printed: 374,347. Filing ↗machine: span 741145–741285 |
| 26 | Section 08, Christopher DelOrefice | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Director Compensation”. As printed: 359,827. Filing ↗machine: span 724573–724713 |
| 27 | Section 08, Karen Drexler | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Director Compensation”. As printed: 354,827. Filing ↗machine: span 727542–727682 |
| 28 | Section 08, Carol Burt | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Director Compensation”. As printed: 351,910. Filing ↗machine: span 718628–718768 |
| 29 | Section 08, Harjit Gill | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Director Compensation”. As printed: 349,827. Filing ↗machine: span 734626–734766 |
| 30 | Section 08, John Hernandez | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Director Compensation”. As printed: 334,827. Filing ↗machine: span 737596–737736 |
| 31 | Section 08, Desney Tan | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Director Compensation”. As printed: 334,827. Filing ↗machine: span 747280–747420 |
| 32 | Section 08, Jan De Witte | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Director Compensation”. As printed: 334,827. Filing ↗machine: span 721594–721734 |
| 33 | Section 08, Richard Sulpizio | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Director Compensation”. As printed: 37,500. Filing ↗machine: span 742408–742547 |
| 34 | Section 08, Michael Farrell | DEF 14A | 2026-10-01 | 0000943819-26-000080 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 35 | Section 02, Michael J. Farrell 2026-10-07 | Form 4 | 2026-10-08 | 0000943819-26-000085 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 36 | Section 02, Michael J. Farrell 2026-10-07 | Form 4 | 2026-10-08 | 0000943819-26-000085 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 37 | Section 02, Michael J. Farrell 2026-10-07 | Form 4 | 2026-10-08 | 0000943819-26-000085 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 38 | Section 06, 2025 vote | Form 8-K | 2025-11-20 | 0001193125-25-289878 | Item 5.07 · say-on-pay result. As reported: 89.94% (votes for as printed: 98,435,762). Filing ↗ |
| 39 | Section 06, 2024 vote | Form 8-K | 2024-11-21 | 0001193125-24-263501 | Item 5.07 · say-on-pay result. As reported: 84.31% (votes for as printed: 92,885,004). Filing ↗ |
| 40 | Section 06, 2023 vote | Form 8-K | 2023-11-20 | 0001193125-23-280656 | Item 5.07 · say-on-pay result. As reported: 81.1% (votes for as printed: 84,318,661). Filing ↗ |
| 41 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 42 | Section 03b vehicle mix (computed) | Computed | — | — | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 43 | Section 09b board cost (computed) | Computed | — | — | Cash 885,833 + equity 2,396,559 + all other 345,863 = 3,628,255, summed across the director compensation table rows.machine: formula: Σ = 3,628,255 |
| 44 | Baxter International, Inc., Section 10b CEO total | DEF 14A | 2026-03-23 | 0001628280-26-020330 | CEO total compensation as printed in Baxter International, Inc.'s own proxy. As printed: 29,805,182. Filing ↗machine: r4 · c30 · span 1451066–1451076 |
| 45 | Intuitive Surgical, Inc., Section 10b CEO total | DEF 14A | 2026-03-13 | 0001035267-26-000023 | CEO total compensation as printed in Intuitive Surgical, Inc.'s own proxy. As printed: 20,997,480. Filing ↗machine: r2 · c48 · span 762289–762299 |
| 46 | Align Technology, Inc., Section 10b CEO total | DEF 14A | 2026-04-07 | 0001097149-26-000023 | CEO total compensation as printed in Align Technology, Inc.'s own proxy. As printed: 19,193,988. Filing ↗machine: r2 · c42 · span 933168–933178 |
| 47 | Edwards Lifesciences Corp., Section 10b CEO total | DEF 14A | 2026-03-26 | 0001099800-26-000015 | CEO total compensation as printed in Edwards Lifesciences Corp.'s own proxy. As printed: 17,454,255. Filing ↗machine: r2 · c27 · span 965441–965451 |
| 48 | RESMED INC (subject), Section 10b CEO total | DEF 14A | 2026-10-01 | 0000943819-26-000080 | CEO total compensation as printed in RESMED INC's own proxy. As printed: 16,201,649. Filing ↗machine: span 1267106–1267116 |
| 49 | The Cooper Companies Inc., Section 10b CEO total | DEF 14A | 2026-02-24 | 0001628280-26-011110 | CEO total compensation as printed in The Cooper Companies Inc.'s own proxy. As printed: 16,051,141. Filing ↗machine: t120 · r3 · c14 · span 744904–744914 |
| 50 | Hologic Inc., Section 10b CEO total | DEF 14A | 2025-01-16 | 0001140361-25-001287 | CEO total compensation as printed in Hologic Inc.'s own proxy. As printed: 15,819,261. Filing ↗machine: r2 · c25 · span 1549664–1549674 |
| 51 | Charles River Laboratories International, Inc., Section 10b CEO total | DEF 14A | 2026-03-31 | 0001104659-26-037367 | CEO total compensation as printed in Charles River Laboratories International, Inc.'s own proxy. As printed: 15,435,220. Filing ↗machine: r1 · c53 · span 1119658–1119668 |
| 52 | IDEXX Laboratories, Inc., Section 10b CEO total | DEF 14A | 2026-03-27 | 0000874716-26-000064 | CEO total compensation as printed in IDEXX Laboratories, Inc.'s own proxy. As printed: 14,580,122. Filing ↗machine: span 1576008–1576018 |
| 53 | Waters Corporation, Section 10b CEO total | DEF 14A | 2026-04-09 | 0001193125-26-149657 | CEO total compensation as printed in Waters Corporation's own proxy. As printed: 13,973,044. Filing ↗machine: r5 · c18 · span 568522–568533 |
| 54 | Agilent Technologies, Inc., Section 10b CEO total | DEF 14A | 2026-02-06 | 0001193125-26-040286 | CEO total compensation as printed in Agilent Technologies, Inc.'s own proxy. As printed: 12,827,236. Filing ↗machine: r3 · c29 · span 1450982–1450992 |
| 55 | Xero, Section 10b CEO total | DEF 14A | 2026-04-07 | 0001770450-26-000020 | CEO total compensation as printed in Xero's own proxy. As printed: 12,581,826. Filing ↗machine: r2 · c27 · span 752773–752783 |
| 56 | Illumina, Inc., Section 10b CEO total | DEF 14A | 2026-04-09 | 0001193125-26-149669 | CEO total compensation as printed in Illumina, Inc.'s own proxy. As printed: 11,018,895. Filing ↗machine: r4 · c14 · span 728526–728536 |
| 57 | Bio-Rad Laboratories, Inc., Section 10b CEO total | DEF 14A | 2026-03-25 | 0000012208-26-000020 | CEO total compensation as printed in Bio-Rad Laboratories, Inc.'s own proxy. As printed: 7,995,841. Filing ↗machine: r2 · c24 · span 654200–654209 |
| 58 | Dexcom, Inc., Section 10b CEO total | DEF 14A | 2026-04-15 | 0001093557-26-000061 | CEO total compensation as printed in Dexcom, Inc.'s own proxy. As printed: 7,985,960. Filing ↗machine: span 940364–940373 |
| 59 | Mettler-Toledo International Inc., Section 10b CEO total | DEF 14A | 2026-03-18 | 0001174947-26-000389 | CEO total compensation as printed in Mettler-Toledo International Inc.'s own proxy. As printed: 6,741,212. Filing ↗machine: r2 · c7 · span 643529–643538 |
| 60 | Teleflex Incorporated, Section 10b CEO total | DEF 14A | 2026-04-13 | 0000096943-26-000039 | CEO total compensation as printed in Teleflex Incorporated's own proxy. As printed: 6,732,419. Filing ↗machine: span 558736–558745 |
| 61 | James Hardie Industries PLC, Section 10b CEO total | DEF 14A | 2026-07-01 | 0001628280-26-046522 | CEO total compensation as printed in James Hardie Industries PLC's own proxy. As printed: 6,545,953. Filing ↗machine: r2 · c9 · span 2897477–2897486 |
| 62 | Section 10a, Align Technology, Inc. reciprocity | DEF 14A | — | 0001097149-26-000023 | Align Technology, Inc. names RESMED INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 63 | Section 10a, Charles River Laboratories International, Inc. reciprocity | DEF 14A | — | 0001104659-26-037367 | Charles River Laboratories International, Inc.'s most recent proxy was read; its disclosed peer group does not include RESMED INC. Filing ↗ |
| 64 | Section 10a, Intuitive Surgical, Inc. reciprocity | DEF 14A | — | 0001035267-26-000023 | Intuitive Surgical, Inc. names RESMED INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 65 | Section 10a, IDEXX Laboratories, Inc. reciprocity | DEF 14A | — | 0000874716-26-000064 | IDEXX Laboratories, Inc. names RESMED INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 66 | Section 10a, Dexcom, Inc. reciprocity | DEF 14A | — | 0001093557-26-000061 | Dexcom, Inc. names RESMED INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 67 | Section 10a, The Cooper Companies Inc. reciprocity | DEF 14A | — | 0001628280-26-011110 | The Cooper Companies Inc. names RESMED INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 68 | Section 10a, Amcor reciprocity | DEF 14A | — | 0001748790-25-000032 | Amcor's most recent proxy was read; its disclosed peer group does not include RESMED INC. Filing ↗ |
| 69 | Section 10a, Hologic Inc. reciprocity | DEF 14A | — | 0001140361-25-001287 | Hologic Inc. names RESMED INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 70 | Section 10a, Edwards Lifesciences Corp. reciprocity | DEF 14A | — | 0001099800-26-000015 | Edwards Lifesciences Corp. names RESMED INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 71 | Section 10a, Agilent Technologies, Inc. reciprocity | DEF 14A | — | 0001193125-26-040286 | Agilent Technologies, Inc. names RESMED INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 72 | Section 10a, Teleflex Incorporated reciprocity | DEF 14A | — | 0000096943-26-000039 | Teleflex Incorporated names RESMED INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 73 | Section 10a, Mettler-Toledo International Inc. reciprocity | DEF 14A | — | 0001174947-26-000389 | Mettler-Toledo International Inc. names RESMED INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 74 | Section 10a, Waters Corporation reciprocity | DEF 14A | — | 0001193125-26-149657 | Waters Corporation names RESMED INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 75 | Section 10a, Baxter International, Inc. reciprocity | DEF 14A | — | 0001628280-26-020330 | Baxter International, Inc.'s most recent proxy was read; its disclosed peer group does not include RESMED INC. Filing ↗ |
| 76 | Section 10a, Xero reciprocity | DEF 14A | — | 0001770450-26-000020 | Xero's most recent proxy was read; its disclosed peer group does not include RESMED INC. Filing ↗ |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.
Get the RESMED INC Executive Compensation Report
$1,500